Traws Pharma, Inc.
Q3 2025 13F Holders
Symbol
TRAW
CUSIP
68232V884
Type
Equity
Class
COM NEW
Num filings
18
Total reported value, excl. options
$2.41 M
Compare 2025 Q3 to
2026 Q2
2026 Q1
2025 Q4
2025 Q2
2025 Q1
2024 Q4
2024 Q3
Manager
Report Date
Value ($000)
Shares
Option Type